Navigation Links
A Drug That Can Keep Cancer In Check

There are several different drugs, therapies, and options for every different type of cancer.Now, researchers say they’ve found one drug that may successfully treat everything from breast to prostate cancer.//
In a study of 22 patients with breast, prostate, lung, ovarian, colon and pancreatic cancer, 42 percent had their tumors either stabilize or shrink by more than 50 percent.
Specialists say , it turns off one of the switches within the cancer cell to stop it from growing, and so there’s much less side effects because it targets the cancer, rather than targeting the whole body. According to researchers it is effective in treating Lung cancer, ovarian cancer, breast cancer, prostate cancer and several others.

Not only did early trials show it might help different types of cancer but it was also found to be effective against the toughest to treat cancers . Thus specialists say that the new findings have given them some hope as they can now take patients with advanced cancer and give them a therapy with very few side effects that stops the growth of the disease.

Since 2C4targets the pathway, rather than the tumor, it has little toxicity. The drug is now being tested in hundreds of patients worldwide and researchers are currently recruiting patients with lung or prostate cancer.


'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... , ... December 05, 2016 , ... ... today that they have teamed up with The American College of Surgeons (ACS) ... ACS’s Committee on Trauma, the “Bleeding Control Basic” course is a pilot program ...
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... (PRWEB) , ... December 03, ... ... German Newall wins "Best Surgical Body Shaping" at the 2016 Anti-Aging ... in Paris, France. , The Aesthetic & Anti-Aging Medicine European Congress ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who ... now take advantage of a cosmetic procedure known as Carbon Dioxide (C02) ... the appearance of age spots, fine lines, uneven coloration, wrinkles, scarring, skin ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Halfway through its ... has provided preventative dental services to more than 15,900 children 5 years old and ... LA pledged $38 million over a span of five years to Western University of ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016 The U.S. Food ... Jardiance (empagliflozin) to reduce the risk of cardiovascular death ... cardiovascular disease. "Cardiovascular disease is a ... diabetes mellitus," said Jean-Marc Guettier , M.D., C.M., ... in FDA,s Center for Drug Evaluation and Research. "Availability ...
(Date:12/2/2016)... , December 2, 2016 Persistence ... pacemaker market in its upcoming report titled, "Global Market Study on ... Declining CAGR of -1.4% between 2016 and 2024". The global ... in 2015 and this is likely to decline to ... the global cardiac pacemaker market is anticipated to exhibit ...
(Date:12/2/2016)... 2016 According to the latest market ... on Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product ... 2016 and 2024 " the global automated endoscope reprocessors market was valued at ... at a CAGR of 7.2% during an eight-year forecast period ... by 2024. ...
Breaking Medicine Technology: